相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma cultures
Aleksei A. Stepanenko et al.
MOLECULAR THERAPY-ONCOLYTICS (2022)
There is still no evidence of SARS-CoV-2 laboratory origin: Response to Segreto and Deigin (10.1002/bies.202100137)
Alexander Tyshkovskiy et al.
BIOESSAYS (2021)
Multi-Omics Analysis of Glioblastoma Cells' Sensitivity to Oncolytic Viruses
Anastasiya V. Lipatova et al.
CANCERS (2021)
Adenovirus Type 6: Subtle Structural Distinctions from Adenovirus Type 5 Result in Essential Differences in Properties and Perspectives for Gene Therapy
Margarita Romanenko et al.
PHARMACEUTICS (2021)
Efficient antiglioblastoma therapy in mice through doxorubicin-loaded nanomicelles modified using a novel brain-targeted RVG-15 peptide
Mingfeng Han et al.
JOURNAL OF DRUG TARGETING (2021)
Double Recombinant Vaccinia Virus: A Candidate Drug against Human Glioblastoma
Natalia Vasileva et al.
LIFE-BASEL (2021)
Intratumoral Virotherapy with Wild-Type Newcastle Disease Virus in Carcinoma Krebs-2 Cancer Model
Kseniya S. Yurchenko et al.
VIRUSES-BASEL (2021)
Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signaling
Michael C. Brown et al.
NATURE COMMUNICATIONS (2021)
Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma
Georgia M. Beasley et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Repurposing Infectious Diseases Vaccines Against Cancer
Liese Vandeborne et al.
FRONTIERS IN ONCOLOGY (2021)
Next Step in Gene Delivery: Modern Approaches and Further Perspectives of AAV Tropism Modification
Maxim A. Korneyenkov et al.
PHARMACEUTICS (2021)
Long-Term Fate of Magnetic Particles in Mice: A Comprehensive Study
Ivan Zelepukin et al.
ACS NANO (2021)
Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Jacek Hajda et al.
CLINICAL CANCER RESEARCH (2021)
What we know and what we need to know about the origin of SARS-CoV-2
Jose L. Domingo
ENVIRONMENTAL RESEARCH (2021)
Step-by-Step Immune Activation for Suicide Gene Therapy Reinforcement
Irina Alekseenko et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial
Jawad Fares et al.
LANCET ONCOLOGY (2021)
Efficacy and safety of oncolytic viruses in advanced or metastatic cancer: a network meta-analysis
Ruiyang Xie et al.
VIROLOGY JOURNAL (2021)
Virotherapy in Germany-Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies
Dirk M. Nettelbeck et al.
VIRUSES-BASEL (2021)
Combinatorial Approaches for Cancer Treatment Using Oncolytic Viruses: Projecting the Perspectives through Clinical Trials Outcomes
Alexander Malogolovkin et al.
VIRUSES-BASEL (2021)
Polymer stealthing and mucin-1 retargeting for enhanced pharmacokinetics of an oncolytic vaccinia virus
Claudia Hill et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
Efficient delivery of oncolytic enterovirus by carrier cell line NK-92
Elizaveta Sergeevna Podshivalova et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
Oncolytic Virus-Induced Autophagy in Glioblastoma
Margarita Kamynina et al.
CANCERS (2021)
A new insight into aggregation of oncolytic adenovirus Ad5-delta-24-RGD during CsCl gradient ultracentrifugation
Aleksei A. Stepanenko et al.
SCIENTIFIC REPORTS (2021)
Targeted Drug Delivery in Brain Tumors-nanochemistry Applications and Advances
Babak Ganjeifar et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2021)
Review of talimogene laherparepvec: A first-in-class oncolytic viral treatment of advanced melanoma
Karyn Haitz et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
The Susceptibility of Human Melanoma Cells to Infection with the Leningrad-16 Vaccine Strain of Measles Virus
Yulia Ammour et al.
VIRUSES-BASEL (2020)
Spectrum-Wide Exploration of Human Adenoviruses for Breast Cancer Therapy
Nicolas Mach et al.
CANCERS (2020)
Delivery and Biosafety of Oncolytic Virotherapy
Lizhi Li et al.
FRONTIERS IN ONCOLOGY (2020)
Developing oncolytic viruses for clinical use: A consortium approach
Vera Kemp et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
Oncolytic virotherapy for pancreatic ductal adenocarcinoma: A glimmer of hope after years of disappointment?
Evelyne Tassone et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
Epidemics as an adaptive driving force determining lifespan setpoints
Peter V. Lidsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Clinical Application of Oncolytic Viruses: A Systematic Review
Mary Cook et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Denis Y. Logunov et al.
LANCET (2020)
AAV-mediated gene transfer of DNase I in the liver of mice with colorectal cancer reduces liver metastasis and restores local innate and adaptive immune response
Yujia Xia et al.
MOLECULAR ONCOLOGY (2020)
Advancements in the Blood-Brain Barrier Penetrating Nanoplatforms for Brain Related Disease Diagnostics and Therapeutic Applications
Suresh Thangudu et al.
POLYMERS (2020)
Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma A Randomized Clinical Trial
Timothy F. Cloughesy et al.
JAMA ONCOLOGY (2020)
Extracellular Vesicle-Based Therapeutics: Preclinical and Clinical Investigations
Natalia L. Klyachko et al.
PHARMACEUTICS (2020)
Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations
Yana Zorkina et al.
MOLECULES (2020)
Induction of Durable Antitumor Response by a Novel Oncolytic Herpesvirus Expressing Multiple Immunomodulatory Transgenes
Dmitry V. Chouljenko et al.
BIOMEDICINES (2020)
Recombinant Vaccinia Virus Promising for Melanoma Treatment
T. V. Bauer et al.
MOLECULAR GENETICS MICROBIOLOGY AND VIROLOGY (2020)
Biomimetic drug delivery platforms based on mesenchymal stem cells impregnated with light-responsive submicron sized carriers
Albert R. Muslimov et al.
BIOMATERIALS SCIENCE (2020)
Adaptation of the Newcastle Disease Virus to Cell Cultures for Enhancing Its Oncolytic Properties
K. S. Yurchenko et al.
ACTA NATURAE (2019)
Oncolytic Activity of the Vaccine Strain of Type 3 Poliovirus on the Model of Rat Glioma C6 Cells
A. O. Sosnovtseva et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2019)
Oncolytic Effect of Adenoviruses Serotypes 5 and 6 Against U87 Glioblastoma Cancer Stem Cells
Margarita V. Romanenko et al.
ANTICANCER RESEARCH (2019)
Engineering oncolytic vaccinia virus with functional peptides through mild and universal strategy
Li-Li Huang et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2019)
Approaching infinite affinity through engineering of peptide-protein interaction
Anthony H. Keeble et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Directed evolution as a tool for the selection of oncolytic RNA viruses with desired phenotypes
Sergei S. Zaindiutnov et al.
ONCOLYTIC VIROTHERAPY (2019)
Targeted Therapy of Human Glioblastoma Combining the Oncolytic Properties of Parvovirus H-1 and Attenuated Strains of the Vaccinia Virus
A. V. Tkacheva et al.
MOLECULAR GENETICS MICROBIOLOGY AND VIROLOGY (2019)
Oncorine, the World First Oncolytic Virus Medicine and its Update in China
Min Liang
CURRENT CANCER DRUG TARGETS (2018)
Oncolytic Paramyxoviruses: Mechanism of Action, Preclinical and Clinical Studies
O. V. Matveeva et al.
MOLECULAR BIOLOGY (2018)
Tamoxifen overrides autophagy inhibition in Beclin-1-deficient glioma cells and their resistance to adenovirus-mediated oncolysis via upregulation of PUMA and BAX
Natalya Kaverina et al.
ONCOGENE (2018)
Oncolytic effect of wild-type Newcastle disease virus isolates in cancer cell lines in vitro and in vivo on xenograft model
Kseniya S. Yurchenko et al.
PLOS ONE (2018)
The advent of oncolytic virotherapy in oncology: The Rigvir® story
Peteris Alberts et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
A compendium of adenovirus genetic modifications for enhanced replication, oncolysis, and tumor immunosurveillance in cancer therapy
Aleksei A. Stepanenko et al.
GENE (2018)
Defects in interferon pathways as potential biomarkers of sensitivity to oncolytic viruses
Olga V. Matveeva et al.
REVIEWS IN MEDICAL VIROLOGY (2018)
Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: Focus on fiber chimerism and mosaicism, hexon and pIX
Aleksei A. Stepanenko et al.
VIRUS RESEARCH (2018)
Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy?
Aleksei A. Stepanenko et al.
CANCERS (2018)
Recombinant Viruses for Cancer Therapy
Daria S. Chulpanova et al.
BIOMEDICINES (2018)
PERSISTENCE OF ONCOLYTIC COXSACKIE VIRUS A7 IN SUBCUTANEOUS HUMAN GLIOBLASTOMA XENOGRAFTS IN MICE IN THE CONTEXT OF EXPERIMENTAL THERAPY
A. S. Sidorenko et al.
BULLETIN OF RUSSIAN STATE MEDICAL UNIVERSITY (2018)
CHANGES IN THE SENSITIVITY OF HUMAN GLIOBLASTOMA CELLS TO ONCOLYTIC ENTEROVIRUSES INDUCED BY PASSAGING
A. Soboleva et al.
BULLETIN OF RUSSIAN STATE MEDICAL UNIVERSITY (2018)
Zika virus has an oncolytic activity against human glioblastoma U87 cells
V. A. Svyatchenko et al.
VAVILOVSKII ZHURNAL GENETIKI I SELEKTSII (2018)
HUMAN ENTEROVIRUSES EXHIBIT SELECTIVE ONCOLYTIC ACTIVITY IN THE MODEL OF HUMAN GLIOBLASTOMA MULTIFORME XENOGRAFTS IN IMMUNODEFICIENT MICE
A. O. Zheltukhin et al.
BULLETIN OF RUSSIAN STATE MEDICAL UNIVERSITY (2018)
Oncolytic Sendai Virus Therapy of Canine Mast Cell Tumors (A Pilot Study)
Galina V. Ilyinskaya et al.
FRONTIERS IN VETERINARY SCIENCE (2018)
Zika virus has oncolytic activity against glioblastoma stem cells
Zhe Zhu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Change in Oncolytic Activity of Sendai Virus during Adaptation to Cell Cultures
S. S. Zainutdinov et al.
MOLECULAR GENETICS MICROBIOLOGY AND VIROLOGY (2017)
Retargeting Lentiviruses via SpyCatcher-SpyTag Chemistry for Gene Delivery into Specific Cell Types
Nagarjun Kasaraneni et al.
MBIO (2017)
Recombinant Vaccinia Viruses Coding Transgenes of Apoptosis-Inducing Proteins Enhance Apoptosis But Not Immunogenicity of Infected Tumor Cells
Olga Koval et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Bioselection of coxsackievirus B6 strain variants with altered tropism to human cancer cell lines
Victor A. Svyatchenko et al.
ARCHIVES OF VIROLOGY (2017)
Highly Effective Production of Biologically Active, Secreted, Human Granulocyte-Macrophage Colony-Stimulating Factor by Recombinant Vaccinia Virus
A. A. Grazhdantseva et al.
APPLIED BIOCHEMISTRY AND MICROBIOLOGY (2016)
Sensitivity of C6 Glioma Cells Carrying the Human Poliovirus Receptor to Oncolytic Polioviruses
A. O. Sosnovtseva et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2016)
Oncolytic virus efficiency inhibited growth of tumour cells with multiple drug resistant phenotype in vivo and in vitro
Elena P. Goncharova et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
The in vivo Antitumor Effect of the Apoptin-Producing Recombinant Vaccinia Virus Strain Is Associated with Blockage of Mitotic Division of Cancer Cells
E. V. Zonov et al.
MOLECULAR GENETICS MICROBIOLOGY AND VIROLOGY (2016)
Evolving lessons on nanomaterial-coated viral vectors for local and systemic gene therapy
Dayananda Kasala et al.
NANOMEDICINE (2016)
Features of the Antitumor Effect of Vaccinia Virus Lister Strain
Evgeniy Zonov et al.
VIRUSES-BASEL (2016)
Engineering of double recombinant vaccinia virus with enhanced oncolytic potential for solid tumor virotherapy
Galina Kochneva et al.
ONCOTARGET (2016)
Breaking resistance of pancreatic cancer cells to an attenuated vesicular stomatitis virus through a novel activity of IKK inhibitor TPCA-1
Marcela Cataldi et al.
VIROLOGY (2015)
Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency
Olga V. Matveeva et al.
MOLECULAR THERAPY-ONCOLYTICS (2015)
Oncolysis by paramyxoviruses: preclinical and clinical studies
Olga V. Matveeva et al.
MOLECULAR THERAPY-ONCOLYTICS (2015)
Mechanisms of Oncolysis by Paramyxovirus Sendai
O. V. Matveeva et al.
ACTA NATURAE (2015)
Apoptin enhances the oncolytic properties of vaccinia virus and modifies mechanisms of tumor regression
Galina Kochneva et al.
ONCOTARGET (2014)
Healing after death: antitumor immunity induced by oncolytic adenoviral therapy
Hong Jiang et al.
ONCOIMMUNOLOGY (2014)
Oncolytic adenoviruses: A thorny path to glioma cure
I. V. Ulasov et al.
GENES & DISEASES (2014)
Apoptin enhances the oncolytic activity of vaccinia virus in vitro
G. V. Kochneva et al.
MOLECULAR BIOLOGY (2013)
Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial
Manfred Westphal et al.
LANCET ONCOLOGY (2013)
Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol
Karsten Geletneky et al.
BMC CANCER (2012)
Targeted and Armed Oncolytic Poxviruses for Cancer: the Lead Example of JX-594
Caroline J. Breitbach et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
Oncolytic enteroviruses
P. M. Chumakov et al.
MOLECULAR BIOLOGY (2012)
Oncolytic adenoviruses in anticancer therapy: Current status and prospects
V. A. Svyatchenko et al.
MOLECULAR BIOLOGY (2012)
Oncolytic poxviruses
G. V. Kochneva et al.
MOLECULAR GENETICS MICROBIOLOGY AND VIROLOGY (2012)
Isolation of Reovirus T3D Mutants Capable of Infecting Human Tumor Cells Independent of Junction Adhesion Molecule-A
Diana J. M. van den Wollenberg et al.
PLOS ONE (2012)
Hyaluronidase Expression by an Oncolytic Adenovirus Enhances Its Intratumoral Spread and Suppresses Tumor Growth
Sonia Guedan et al.
MOLECULAR THERAPY (2010)
Multiple hepatic arterial injections of recombinant adenovirus p53 and 5-fluorouracil after transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a pilot phase II trial
Geng Tian et al.
ANTI-CANCER DRUGS (2009)
The p73 DNA binding domain displays enhanced stability relative to its homologue, the tumor suppressor p53, and exhibits cooperative DNA binding
Seema Patel et al.
BIOCHEMISTRY (2008)
Viral vectors based on bidirectional cell-specific mammalian promoters and transcriptional amplification strategy for use in vitro and in vivo
Beihui Liu et al.
BMC BIOTECHNOLOGY (2008)
Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma
Adam M. Sonabend et al.
STEM CELLS (2008)
Modification of adenovirus capsid with a designed protein ligand yields a gene vector targeted to a major molecular marker of cancer
Natalya Belousova et al.
JOURNAL OF VIROLOGY (2008)
Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow
Caroline J. Breitbach et al.
MOLECULAR THERAPY (2007)
History of oncolytic viruses: Genesis to genetic engineering
Elizabeth Kelly et al.
MOLECULAR THERAPY (2007)
Restoration of p53 tumor-suppressor activity in human tumor cells in vitro and in their xenografts in vivo by recombinant avian adenovirus CELO-p53
DY Logunov et al.
GENE THERAPY (2004)
Intravascular adenoviral agents in cancer patients: Lessons from clinical trials
T Reid et al.
CANCER GENE THERAPY (2002)
The danger model: A renewed sense of self
P Matzinger
SCIENCE (2002)
Blood clearance rates of adenovirus type 5 in mice
R Alemany et al.
JOURNAL OF GENERAL VIROLOGY (2000)
分享论文
